High-risk Pancreas Clinic

If you have a family history of pancreatic cancer, you want to know if you are at risk.

Since this type of cancer may occur without warning signs or symptoms, early screening and detection are important for the best possible result.

The High-risk Pancreas Clinic at UMass Memorial Medical Center offers the following for those at moderate- or high-risk for pancreatic cancers:

  • Risk assessment – Assessments are completed by a surgical oncologist, gastroenterologist (specialist in digestive disorders) and genetic counselor. During the assessment, members of the team review personal and family history to determine the likelihood of developing pancreatic cancer.
  • Screening – The screening process includes endoscopic studies and radiology testing for early detection of pancreatic changes that might be cancerous or precancerous.
  • Genetic counseling – After reviewing family and personal history, our genetic counselor will consider possible genetic syndromes that may be associated, and if indicated, offers genetic testing.
  • Ongoing surveillance – A plan will be developed for regular monitoring.

Research and Clinical Trials

Working with UMass Medical School, the Cancer Center serves as a forum for education and research. Extensive cancer research and clinical trials are conducted so you benefit from the latest diagnostic and treatment options that come from this research.

Are You At Risk for Pancreatic Cancer?

Patients with a personal or family history (at least one affected family member) or one of the genetic syndromes known to be associated with pancreatic cancer may benefit from screening. Learn about risk factors.

About Pancreatic Cancer

According to the American Cancer Society, about 45,220 new cases of pancreatic cancer will be diagnosed in the United States this year. The lifetime risk of having pancreatic cancer is about one in 78 people. Early detection has the potential to find lesions that could be treated and possibly cured.

Appointments

A call or click away:

 

View our 2016 Cancer Committee Report

2016 Cancer Committee Annual Report